A detailed history of Atom Investors LP transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Atom Investors LP holds 13,499 shares of OLMA stock, worth $65,470. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,499
Holding current value
$65,470
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$3.76 - $6.39 $50,756 - $86,258
13,499 New
13,499 $50,000
Q2 2024

Aug 14, 2024

SELL
$8.73 - $13.99 $522,106 - $836,685
-59,806 Reduced 63.41%
34,515 $373,000
Q1 2024

May 15, 2024

BUY
$10.95 - $16.62 $388,188 - $589,195
35,451 Added 60.22%
94,321 $1.07 Million
Q4 2023

Feb 14, 2024

BUY
$10.53 - $17.14 $619,901 - $1.01 Million
58,870 New
58,870 $825,000
Q1 2021

May 17, 2021

SELL
$27.81 - $53.64 $706,346 - $1.36 Million
-25,399 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$37.09 - $54.5 $942,048 - $1.38 Million
25,399 New
25,399 $1.22 Million

Others Institutions Holding OLMA

About Olema Pharmaceuticals, Inc.


  • Ticker OLMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,419,600
  • Market Cap $196M
  • Description
  • Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...
More about OLMA
Track This Portfolio

Track Atom Investors LP Portfolio

Follow Atom Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Atom Investors LP with notifications on news.